Moderna Inc. stock - "The end of a pandemic Stock"
Moderna, a drugmaker with just a single product to its name
, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.
Shares of Moderna Inc. MRNA, +5.56% slid 9.72% to $111.40 Monday, on what proved to be an all-around favourable
trading session for the stock market, with the NASDAQ Composite Index
#moderna #mrna #Mrna
, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.
Shares of Moderna Inc. MRNA, +5.56% slid 9.72% to $111.40 Monday, on what proved to be an all-around favourable
trading session for the stock market, with the NASDAQ Composite Index
#moderna #mrna #Mrna
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.